Microchip CEO’s entities sell 109,971 MCHP shares
Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan. On April 30, 2026, 33,502 shares were sold at an average price of $92.3729 per share. On May 1, 2026, 76,469 shares were sold at an average price of $93.5843 per share, for total reported sales of 109,971 shares. After these transactions, 9,385,834 shares of Microchip Technology common stock are reported as indirectly held, including shares held by The Sanghi Trust and The Sanghi Family Limited Partnership.
Insights
CEO’s entities sold ~110K Microchip shares but still report large indirect holdings.
The filing shows entities associated with Steve Sanghi executed two open‑market sales totaling 109,971 shares of Microchip Technology common stock at prices around $92–$94 per share. These transactions are reported as indirect, through a trust and a family limited partnership.
A key detail is that the sales were effected under a Rule 10b5‑1 trading plan adopted on June 6, 2025, indicating they were pre‑scheduled rather than opportunistic. After the sales, the filing still reports 9,385,834 shares indirectly held, split between The Sanghi Trust and The Sanghi Family Limited Partnership.
The combination of pre‑planned sales and remaining multi‑million‑share indirect ownership suggests these are portfolio‑management moves rather than a wholesale exit. Future company filings may further update Sanghi’s indirect ownership levels and any additional 10b5‑1 plan activity.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 76,469 | $93.5843 | $7.16M |
| Sale | Common Stock | 33,502 | $92.3729 | $3.09M |
Footnotes (3)
- F1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Sanghi
- F2. Of the 9,462,303 shares held, 3,556,431 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.
- F3. Of the 9,385,834 shares held, 3,479,962 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Family Limited Partnership financial
indirectly held financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock transactions did MICROCHIP TECHNOLOGY (MCHP) report for Steve Sanghi?
Were Steve Sanghi’s MICROCHIP TECHNOLOGY (MCHP) stock sales made under a Rule 10b5-1 plan?
Through which entities does Steve Sanghi indirectly hold MICROCHIP TECHNOLOGY (MCHP) shares?
Is the Form 4 for MICROCHIP TECHNOLOGY (MCHP) a buy or sell transaction for Steve Sanghi?
AI-generated analysis. How Rhea-AI works. Not financial advice.